Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abbreviated lipid guidelines for clinical practice : Based on ESC lipid guidelines 2019 and ESC cardiovascular disease prevention in clinical practice guidelines 2021.

Irish journal of medical science·2023
Same author

Investigational therapies for hypercholesterolemia.

Expert opinion on investigational drugs·2017
Same author

Obesity diabetes and the role of bile acids in metabolism.

Journal of translational internal medicine·2017
Same author

Dyslipidaemia of diabetes and the intestine.

World journal of diabetes·2015
Same author

Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

World journal of diabetes·2014
Same author

Investigational therapies for the treatment of atherosclerosis.

Expert opinion on investigational drugs·2014

Related Experiment Videos

The chylomicron: relationship to atherosclerosis.

Gerald H Tomkin1, Daphne Owens

  • 1Diabetes Institute of Ireland, Beacon Clinic, Sandyford, Dublin 18, Ireland.

International Journal of Vascular Medicine
|October 19, 2011
PubMed
Summary

Dietary cholesterol and statins impact cholesterol absorption and synthesis. Inhibiting cholesterol absorption, like with Ezetimibe, increases synthesis, highlighting the benefit of combined therapies for managing cholesterol and atherosclerosis.

Related Experiment Videos

Area of Science:

  • Lipid metabolism
  • Cardiovascular disease research
  • Atherosclerosis pathogenesis

Background:

  • B-containing lipoproteins, including chylomicrons (apo B48) and very low-density lipoprotein (VLDL), are key cholesterol transporters.
  • These lipoproteins influence low-density lipoprotein (LDL) composition, contributing to plaque development.
  • Dietary cholesterol intervention has limited impact on serum cholesterol levels (<20%).

Purpose of the Study:

  • To discuss cholesterol absorption and synthesis pathways.
  • To explore chylomicron formation and its regulation.
  • To examine the impact of postprandial lipoproteins on atherosclerosis.

Main Methods:

  • Review of existing evidence on lipoprotein function and cholesterol metabolism.
  • Analysis of the interplay between cholesterol synthesis and absorption.
  • Discussion of pharmacological interventions like statins and Ezetimibe.

Main Results:

  • Statins, while reducing cholesterol, can increase cholesterol absorption.
  • Ezetimibe inhibits Niemann-Pick C1-like 1 (NPC1-L1), a key regulator of cholesterol absorption, leading to increased cholesterol synthesis.
  • Combined inhibition of absorption and synthesis offers a synergistic therapeutic approach.

Conclusions:

  • Understanding the intricate relationship between cholesterol synthesis and absorption is crucial for effective lipid management.
  • Postprandial lipoproteins play a significant role in atherosclerosis development.
  • Targeting cholesterol absorption and synthesis pathways holds promise for cardiovascular disease prevention.